APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tyrosine Protein Kinase JAK1

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tyrosine Protein Kinase JAK1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchTyrosine Protein Kinase JAK1 Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Tyrosine Protein Kinase JAK1 Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Tyrosine Protein Kinase JAK1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tyrosine Protein Kinase JAK1 Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Tyrosine Protein Kinase JAK1 Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Tyrosine Protein Kinase JAK1 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Tyrosine Protein Kinase JAK1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tyrosine Protein Kinase JAK1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tyrosine Protein Kinase JAK1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tyrosine Protein Kinase JAK1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tyrosine Protein Kinase JAK1 include Eli Lilly and Co, Jiangsu Hengrui Medicine Co Ltd, Pfizer Inc, AbbVie Inc, AstraZeneca Plc, Vectura Group Plc, Theravance Biopharma Inc, Sareum Holdings Plc and Portola Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tyrosine Protein Kinase JAK1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tyrosine Protein Kinase JAK1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tyrosine Protein Kinase JAK1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tyrosine Protein Kinase JAK1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Tyrosine Protein Kinase JAK1 Segment by Company

Eli Lilly and Co

Jiangsu Hengrui Medicine Co Ltd

Pfizer Inc

AbbVie Inc

AstraZeneca Plc

Vectura Group Plc

Theravance Biopharma Inc

Sareum Holdings Plc

Portola Pharmaceuticals Inc

Nissan Chemical Industries Ltd

Japan Tobacco Inc

Incyte Corp

Galapagos NV

Concert Pharmaceuticals Inc

CJ HealthCare Corp

Chipscreen Biosciences Ltd

Bristol-Myers Squibb Co

Astellas Pharma Inc

Aclaris Therapeutics Inc

Tyrosine Protein Kinase JAK1 Segment by Type

AZD-4205

CJ-15314

Cerdulatinib

Baricitinib

Others

Tyrosine Protein Kinase JAK1 Segment by Application

Eosinophilia

Cutaneous Lupus Erythematosus

Hairy Cell Leukemia

Others

Tyrosine Protein Kinase JAK1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tyrosine Protein Kinase JAK1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tyrosine Protein Kinase JAK1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tyrosine Protein Kinase JAK1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tyrosine Protein Kinase JAK1 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tyrosine Protein Kinase JAK1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Tyrosine Protein Kinase JAK1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Tyrosine Protein Kinase JAK1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Tyrosine Protein Kinase JAK1 Industry Trends Table 2. Tyrosine Protein Kinase JAK1 Industry Drivers Table 3. Tyrosine Protein Kinase JAK1 Industry Opportunities and Challenges Table 4. Tyrosine Protein Kinase JAK1 Industry Restraints Table 5. Global Tyrosine Protein Kinase JAK1 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Tyrosine Protein Kinase JAK1 Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Manufacturers Table 9. Global Tyrosine Protein Kinase JAK1 Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Tyrosine Protein Kinase JAK1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tyrosine Protein Kinase JAK1 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Tyrosine Protein Kinase JAK1 Manufacturers, Product Type & Application Table 13. Global Tyrosine Protein Kinase JAK1 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tyrosine Protein Kinase JAK1 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of AZD-4205 Table 17. Major Manufacturers of CJ-15314 Table 18. Major Manufacturers of Cerdulatinib Table 19. Major Manufacturers of Baricitinib Table 20. Major Manufacturers of Others Table 21. Global Tyrosine Protein Kinase JAK1 Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Tyrosine Protein Kinase JAK1 Sales by Type (2021-2026) & (k units) Table 23. Global Tyrosine Protein Kinase JAK1 Sales by Type (2027-2032) & (k units) Table 24. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2021-2026) Table 25. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2027-2032) Table 26. Global Tyrosine Protein Kinase JAK1 Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Tyrosine Protein Kinase JAK1 Revenue by Type (2021-2026) & (k units) Table 28. Global Tyrosine Protein Kinase JAK1 Revenue by Type (2027-2032) & (k units) Table 29. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Type (2021-2026) Table 30. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Eosinophilia Table 32. Major Manufacturers of Cutaneous Lupus Erythematosus Table 33. Major Manufacturers of Hairy Cell Leukemia Table 34. Major Manufacturers of Others Table 35. Global Tyrosine Protein Kinase JAK1 Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Tyrosine Protein Kinase JAK1 Sales by Application (2021-2026) & (k units) Table 37. Global Tyrosine Protein Kinase JAK1 Sales by Application (2027-2032) & (k units) Table 38. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2021-2026) Table 39. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2027-2032) Table 40. Global Tyrosine Protein Kinase JAK1 Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Tyrosine Protein Kinase JAK1 Revenue by Application (2021-2026) & (k units) Table 42. Global Tyrosine Protein Kinase JAK1 Revenue by Application (2027-2032) & (k units) Table 43. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Application (2021-2026) Table 44. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Application (2027-2032) Table 45. Global Tyrosine Protein Kinase JAK1 Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Tyrosine Protein Kinase JAK1 Sales by Region (2021-2026) & (k units) Table 47. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Region (2021-2026) Table 48. Global Tyrosine Protein Kinase JAK1 Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Tyrosine Protein Kinase JAK1 Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Tyrosine Protein Kinase JAK1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Tyrosine Protein Kinase JAK1 Sales by Country (2021-2026) & (k units) Table 52. North America Tyrosine Protein Kinase JAK1 Sales by Country (2027-2032) & (k units) Table 53. Europe Tyrosine Protein Kinase JAK1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Tyrosine Protein Kinase JAK1 Sales by Country (2021-2026) & (k units) Table 55. Europe Tyrosine Protein Kinase JAK1 Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Tyrosine Protein Kinase JAK1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Tyrosine Protein Kinase JAK1 Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Tyrosine Protein Kinase JAK1 Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Country (2027-2032) & (k units) Table 62. Global Tyrosine Protein Kinase JAK1 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Tyrosine Protein Kinase JAK1 Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Tyrosine Protein Kinase JAK1 Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Region (2021-2026) Table 66. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Region (2027-2032) Table 67. Eli Lilly and Co Company Information Table 68. Eli Lilly and Co Business Overview Table 69. Eli Lilly and Co Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Eli Lilly and Co Tyrosine Protein Kinase JAK1 Product Portfolio Table 71. Eli Lilly and Co Recent Development Table 72. Jiangsu Hengrui Medicine Co Ltd Company Information Table 73. Jiangsu Hengrui Medicine Co Ltd Business Overview Table 74. Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Product Portfolio Table 76. Jiangsu Hengrui Medicine Co Ltd Recent Development Table 77. Pfizer Inc Company Information Table 78. Pfizer Inc Business Overview Table 79. Pfizer Inc Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Pfizer Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 81. Pfizer Inc Recent Development Table 82. AbbVie Inc Company Information Table 83. AbbVie Inc Business Overview Table 84. AbbVie Inc Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. AbbVie Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 86. AbbVie Inc Recent Development Table 87. AstraZeneca Plc Company Information Table 88. AstraZeneca Plc Business Overview Table 89. AstraZeneca Plc Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. AstraZeneca Plc Tyrosine Protein Kinase JAK1 Product Portfolio Table 91. AstraZeneca Plc Recent Development Table 92. Vectura Group Plc Company Information Table 93. Vectura Group Plc Business Overview Table 94. Vectura Group Plc Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Vectura Group Plc Tyrosine Protein Kinase JAK1 Product Portfolio Table 96. Vectura Group Plc Recent Development Table 97. Theravance Biopharma Inc Company Information Table 98. Theravance Biopharma Inc Business Overview Table 99. Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 101. Theravance Biopharma Inc Recent Development Table 102. Sareum Holdings Plc Company Information Table 103. Sareum Holdings Plc Business Overview Table 104. Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Product Portfolio Table 106. Sareum Holdings Plc Recent Development Table 107. Portola Pharmaceuticals Inc Company Information Table 108. Portola Pharmaceuticals Inc Business Overview Table 109. Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 111. Portola Pharmaceuticals Inc Recent Development Table 112. Nissan Chemical Industries Ltd Company Information Table 113. Nissan Chemical Industries Ltd Business Overview Table 114. Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Product Portfolio Table 116. Nissan Chemical Industries Ltd Recent Development Table 117. Japan Tobacco Inc Company Information Table 118. Japan Tobacco Inc Business Overview Table 119. Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 121. Japan Tobacco Inc Recent Development Table 122. Incyte Corp Company Information Table 123. Incyte Corp Business Overview Table 124. Incyte Corp Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Incyte Corp Tyrosine Protein Kinase JAK1 Product Portfolio Table 126. Incyte Corp Recent Development Table 127. Galapagos NV Company Information Table 128. Galapagos NV Business Overview Table 129. Galapagos NV Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Galapagos NV Tyrosine Protein Kinase JAK1 Product Portfolio Table 131. Galapagos NV Recent Development Table 132. Concert Pharmaceuticals Inc Company Information Table 133. Concert Pharmaceuticals Inc Business Overview Table 134. Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 136. Concert Pharmaceuticals Inc Recent Development Table 137. CJ HealthCare Corp Company Information Table 138. CJ HealthCare Corp Business Overview Table 139. CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Product Portfolio Table 141. CJ HealthCare Corp Recent Development Table 142. Chipscreen Biosciences Ltd Company Information Table 143. Chipscreen Biosciences Ltd Business Overview Table 144. Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Product Portfolio Table 146. Chipscreen Biosciences Ltd Recent Development Table 147. Bristol-Myers Squibb Co Company Information Table 148. Bristol-Myers Squibb Co Business Overview Table 149. Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Product Portfolio Table 151. Bristol-Myers Squibb Co Recent Development Table 152. Astellas Pharma Inc Company Information Table 153. Astellas Pharma Inc Business Overview Table 154. Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 156. Astellas Pharma Inc Recent Development Table 157. Aclaris Therapeutics Inc Company Information Table 158. Aclaris Therapeutics Inc Business Overview Table 159. Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 161. Aclaris Therapeutics Inc Recent Development Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Tyrosine Protein Kinase JAK1 Distributors List Table 165. Tyrosine Protein Kinase JAK1 Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Tyrosine Protein Kinase JAK1 Product Image Figure 2. Global Tyrosine Protein Kinase JAK1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tyrosine Protein Kinase JAK1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Tyrosine Protein Kinase JAK1 Sales (2021-2032) & (k units) Figure 5. Global Tyrosine Protein Kinase JAK1 Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Tyrosine Protein Kinase JAK1 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. AZD-4205 Image Figure 9. CJ-15314 Image Figure 10. Cerdulatinib Image Figure 11. Baricitinib Image Figure 12. Others Image Figure 13. Global Tyrosine Protein Kinase JAK1 Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Tyrosine Protein Kinase JAK1 Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2021-2032) Figure 16. Global Tyrosine Protein Kinase JAK1 Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Tyrosine Protein Kinase JAK1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Type (2021-2032) Figure 19. Eosinophilia Image Figure 20. Cutaneous Lupus Erythematosus Image Figure 21. Hairy Cell Leukemia Image Figure 22. Others Image Figure 23. Global Tyrosine Protein Kinase JAK1 Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Tyrosine Protein Kinase JAK1 Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2021-2032) Figure 26. Global Tyrosine Protein Kinase JAK1 Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Tyrosine Protein Kinase JAK1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Application (2021-2032) Figure 29. North America Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2021-2032) Figure 31. U.S. Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2021-2032) Figure 36. Germany Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2021-2032) Figure 43. China Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2021-2032) Figure 51. Brazil Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Tyrosine Protein Kinase JAK1 Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Tyrosine Protein Kinase JAK1 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Tyrosine Protein Kinase JAK1 Revenue (2021-2032) & (US$ Million) Figure 62. North America Tyrosine Protein Kinase JAK1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Tyrosine Protein Kinase JAK1 Revenue (2021-2032) & (US$ Million) Figure 64. Europe Tyrosine Protein Kinase JAK1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Tyrosine Protein Kinase JAK1 Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Tyrosine Protein Kinase JAK1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Tyrosine Protein Kinase JAK1 Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Tyrosine Protein Kinase JAK1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Tyrosine Protein Kinase JAK1 Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Tyrosine Protein Kinase JAK1 Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • AZD-4205
  • CJ-15314
  • Cerdulatinib
  • Baricitinib
  • Others
Applications
  • Eosinophilia
  • Cutaneous Lupus Erythematosus
  • Hairy Cell Leukemia
  • Others
Companies covered
  • Eli Lilly and Co
  • Jiangsu Hengrui Medicine Co Ltd
  • Pfizer Inc
  • AbbVie Inc
  • AstraZeneca Plc
  • Vectura Group Plc
  • Theravance Biopharma Inc
  • Sareum Holdings Plc
  • Portola Pharmaceuticals Inc
  • Nissan Chemical Industries Ltd
  • Japan Tobacco Inc
  • Incyte Corp
  • Galapagos NV
  • Concert Pharmaceuticals Inc
  • CJ HealthCare Corp
  • Chipscreen Biosciences Ltd
  • Bristol-Myers Squibb Co
  • Astellas Pharma Inc
  • Aclaris Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tyrosine Protein Kinase JAK1 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tyrosine Protein Kinase JAK1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Tyrosine Protein Kinase JAK1 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Tyrosine Protein Kinase JAK1 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Tyrosine Protein Kinase JAK1 Market Dynamics
  1. 2.1 Tyrosine Protein Kinase JAK1 Industry Trends
  2. 2.2 Tyrosine Protein Kinase JAK1 Industry Drivers
  3. 2.3 Tyrosine Protein Kinase JAK1 Industry Opportunities and Challenges
  4. 2.4 Tyrosine Protein Kinase JAK1 Industry Restraints
3 Tyrosine Protein Kinase JAK1 Market by Manufacturers
  1. 3.1 Global Tyrosine Protein Kinase JAK1 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Tyrosine Protein Kinase JAK1 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Tyrosine Protein Kinase JAK1 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Tyrosine Protein Kinase JAK1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tyrosine Protein Kinase JAK1 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Tyrosine Protein Kinase JAK1 Manufacturers, Product Type & Application
  7. 3.7 Global Tyrosine Protein Kinase JAK1 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tyrosine Protein Kinase JAK1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tyrosine Protein Kinase JAK1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tyrosine Protein Kinase JAK1 Tier 1, Tier 2, and Tier 3
4 Tyrosine Protein Kinase JAK1 Market by Type
  1. 4.1 Tyrosine Protein Kinase JAK1 Type Introduction
  2. 4.1.1 AZD-4205
  3. 4.1.2 CJ-15314
  4. 4.1.3 Cerdulatinib
  5. 4.1.4 Baricitinib
  6. 4.1.5 Others
  7. 4.2 Global Tyrosine Protein Kinase JAK1 Sales by Type
  8. 4.2.1 Global Tyrosine Protein Kinase JAK1 Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Tyrosine Protein Kinase JAK1 Sales by Type (2021-2032)
  10. 4.2.3 Global Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2021-2032)
  11. 4.3 Global Tyrosine Protein Kinase JAK1 Revenue by Type
  12. 4.3.1 Global Tyrosine Protein Kinase JAK1 Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Tyrosine Protein Kinase JAK1 Revenue by Type (2021-2032)
  14. 4.3.3 Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Type (2021-2032)
5 Tyrosine Protein Kinase JAK1 Market by Application
  1. 5.1 Tyrosine Protein Kinase JAK1 Application Introduction
  2. 5.1.1 Eosinophilia
  3. 5.1.2 Cutaneous Lupus Erythematosus
  4. 5.1.3 Hairy Cell Leukemia
  5. 5.1.4 Others
  6. 5.2 Global Tyrosine Protein Kinase JAK1 Sales by Application
  7. 5.2.1 Global Tyrosine Protein Kinase JAK1 Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Tyrosine Protein Kinase JAK1 Sales by Application (2021-2032)
  9. 5.2.3 Global Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2021-2032)
  10. 5.3 Global Tyrosine Protein Kinase JAK1 Revenue by Application
  11. 5.3.1 Global Tyrosine Protein Kinase JAK1 Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Tyrosine Protein Kinase JAK1 Revenue by Application (2021-2032)
  13. 5.3.3 Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Application (2021-2032)
6 Global Tyrosine Protein Kinase JAK1 Sales by Region
  1. 6.1 Global Tyrosine Protein Kinase JAK1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tyrosine Protein Kinase JAK1 Sales by Region (2021-2032)
  3. 6.2.1 Global Tyrosine Protein Kinase JAK1 Sales by Region (2021-2026)
  4. 6.2.2 Global Tyrosine Protein Kinase JAK1 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tyrosine Protein Kinase JAK1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tyrosine Protein Kinase JAK1 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tyrosine Protein Kinase JAK1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tyrosine Protein Kinase JAK1 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Tyrosine Protein Kinase JAK1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Tyrosine Protein Kinase JAK1 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Tyrosine Protein Kinase JAK1 Revenue by Region
  1. 7.1 Global Tyrosine Protein Kinase JAK1 Revenue by Region
  2. 7.1.1 Global Tyrosine Protein Kinase JAK1 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Tyrosine Protein Kinase JAK1 Revenue by Region (2021-2026)
  4. 7.1.3 Global Tyrosine Protein Kinase JAK1 Revenue by Region (2027-2032)
  5. 7.1.4 Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Tyrosine Protein Kinase JAK1 Revenue (2021-2032)
  8. 7.2.2 North America Tyrosine Protein Kinase JAK1 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Tyrosine Protein Kinase JAK1 Revenue (2021-2032)
  11. 7.3.2 Europe Tyrosine Protein Kinase JAK1 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Tyrosine Protein Kinase JAK1 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Tyrosine Protein Kinase JAK1 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Tyrosine Protein Kinase JAK1 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Tyrosine Protein Kinase JAK1 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eli Lilly and Co
  2. 8.1.1 Eli Lilly and Co Company Information
  3. 8.1.2 Eli Lilly and Co Business Overview
  4. 8.1.3 Eli Lilly and Co Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eli Lilly and Co Tyrosine Protein Kinase JAK1 Product Portfolio
  6. 8.1.5 Eli Lilly and Co Recent Developments
  7. 8.2 Jiangsu Hengrui Medicine Co Ltd
  8. 8.2.1 Jiangsu Hengrui Medicine Co Ltd Company Information
  9. 8.2.2 Jiangsu Hengrui Medicine Co Ltd Business Overview
  10. 8.2.3 Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Product Portfolio
  12. 8.2.5 Jiangsu Hengrui Medicine Co Ltd Recent Developments
  13. 8.3 Pfizer Inc
  14. 8.3.1 Pfizer Inc Company Information
  15. 8.3.2 Pfizer Inc Business Overview
  16. 8.3.3 Pfizer Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  18. 8.3.5 Pfizer Inc Recent Developments
  19. 8.4 AbbVie Inc
  20. 8.4.1 AbbVie Inc Company Information
  21. 8.4.2 AbbVie Inc Business Overview
  22. 8.4.3 AbbVie Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AbbVie Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  24. 8.4.5 AbbVie Inc Recent Developments
  25. 8.5 AstraZeneca Plc
  26. 8.5.1 AstraZeneca Plc Company Information
  27. 8.5.2 AstraZeneca Plc Business Overview
  28. 8.5.3 AstraZeneca Plc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca Plc Tyrosine Protein Kinase JAK1 Product Portfolio
  30. 8.5.5 AstraZeneca Plc Recent Developments
  31. 8.6 Vectura Group Plc
  32. 8.6.1 Vectura Group Plc Company Information
  33. 8.6.2 Vectura Group Plc Business Overview
  34. 8.6.3 Vectura Group Plc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Vectura Group Plc Tyrosine Protein Kinase JAK1 Product Portfolio
  36. 8.6.5 Vectura Group Plc Recent Developments
  37. 8.7 Theravance Biopharma Inc
  38. 8.7.1 Theravance Biopharma Inc Company Information
  39. 8.7.2 Theravance Biopharma Inc Business Overview
  40. 8.7.3 Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  42. 8.7.5 Theravance Biopharma Inc Recent Developments
  43. 8.8 Sareum Holdings Plc
  44. 8.8.1 Sareum Holdings Plc Company Information
  45. 8.8.2 Sareum Holdings Plc Business Overview
  46. 8.8.3 Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Product Portfolio
  48. 8.8.5 Sareum Holdings Plc Recent Developments
  49. 8.9 Portola Pharmaceuticals Inc
  50. 8.9.1 Portola Pharmaceuticals Inc Company Information
  51. 8.9.2 Portola Pharmaceuticals Inc Business Overview
  52. 8.9.3 Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  54. 8.9.5 Portola Pharmaceuticals Inc Recent Developments
  55. 8.10 Nissan Chemical Industries Ltd
  56. 8.10.1 Nissan Chemical Industries Ltd Company Information
  57. 8.10.2 Nissan Chemical Industries Ltd Business Overview
  58. 8.10.3 Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Product Portfolio
  60. 8.10.5 Nissan Chemical Industries Ltd Recent Developments
  61. 8.11 Japan Tobacco Inc
  62. 8.11.1 Japan Tobacco Inc Company Information
  63. 8.11.2 Japan Tobacco Inc Business Overview
  64. 8.11.3 Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  66. 8.11.5 Japan Tobacco Inc Recent Developments
  67. 8.12 Incyte Corp
  68. 8.12.1 Incyte Corp Company Information
  69. 8.12.2 Incyte Corp Business Overview
  70. 8.12.3 Incyte Corp Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Incyte Corp Tyrosine Protein Kinase JAK1 Product Portfolio
  72. 8.12.5 Incyte Corp Recent Developments
  73. 8.13 Galapagos NV
  74. 8.13.1 Galapagos NV Company Information
  75. 8.13.2 Galapagos NV Business Overview
  76. 8.13.3 Galapagos NV Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Galapagos NV Tyrosine Protein Kinase JAK1 Product Portfolio
  78. 8.13.5 Galapagos NV Recent Developments
  79. 8.14 Concert Pharmaceuticals Inc
  80. 8.14.1 Concert Pharmaceuticals Inc Company Information
  81. 8.14.2 Concert Pharmaceuticals Inc Business Overview
  82. 8.14.3 Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  84. 8.14.5 Concert Pharmaceuticals Inc Recent Developments
  85. 8.15 CJ HealthCare Corp
  86. 8.15.1 CJ HealthCare Corp Company Information
  87. 8.15.2 CJ HealthCare Corp Business Overview
  88. 8.15.3 CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Product Portfolio
  90. 8.15.5 CJ HealthCare Corp Recent Developments
  91. 8.16 Chipscreen Biosciences Ltd
  92. 8.16.1 Chipscreen Biosciences Ltd Company Information
  93. 8.16.2 Chipscreen Biosciences Ltd Business Overview
  94. 8.16.3 Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Product Portfolio
  96. 8.16.5 Chipscreen Biosciences Ltd Recent Developments
  97. 8.17 Bristol-Myers Squibb Co
  98. 8.17.1 Bristol-Myers Squibb Co Company Information
  99. 8.17.2 Bristol-Myers Squibb Co Business Overview
  100. 8.17.3 Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Product Portfolio
  102. 8.17.5 Bristol-Myers Squibb Co Recent Developments
  103. 8.18 Astellas Pharma Inc
  104. 8.18.1 Astellas Pharma Inc Company Information
  105. 8.18.2 Astellas Pharma Inc Business Overview
  106. 8.18.3 Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  108. 8.18.5 Astellas Pharma Inc Recent Developments
  109. 8.19 Aclaris Therapeutics Inc
  110. 8.19.1 Aclaris Therapeutics Inc Company Information
  111. 8.19.2 Aclaris Therapeutics Inc Business Overview
  112. 8.19.3 Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  114. 8.19.5 Aclaris Therapeutics Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tyrosine Protein Kinase JAK1 Value Chain Analysis
  2. 9.1.1 Tyrosine Protein Kinase JAK1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tyrosine Protein Kinase JAK1 Production Mode & Process
  6. 9.2 Tyrosine Protein Kinase JAK1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tyrosine Protein Kinase JAK1 Distributors
  9. 9.2.3 Tyrosine Protein Kinase JAK1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst